Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, 1600 NW 10th Ave, Room 2023, Miami, FL, 33136, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
Arch Dermatol Res. 2023 Apr;315(3):625-627. doi: 10.1007/s00403-022-02384-6. Epub 2022 Aug 17.
With the onset of the COVID-19 pandemic, the dermatology residency application process rapidly transitioned in a number of dimensions. As in-person activities were canceled and USMLE Step 1 has become pass/fail, there have been several proposed changes to enhance the process, including a push for increased transparency. Given than most dermatology applicants use program websites to learn more about potential residency programs, we conducted a cross-sectional study to quantify how transparent dermatology residency program website were, relative to published guidelines. From February 11, 2022, to February 25, 2022, we examined the available websites of all ACGME-accredited dermatology residencies to determine transparency regarding information dissemination, selection criteria, interview process, program priorities, and program requirements and opportunities. 136 out of 143 dermatology programs (95.1%) were included. Overall, programs were most transparent with program requirements and opportunities (87.25%). This included information on hospital locations, subspecialty clinics, and rotation/call/didactic schedules. Programs were least transparent with sharing their selection and/or exclusion criteria (31.13%) and varied in how much information they shared about the interview process (39.34%), as well as program priorities (64.56%). Opportunities remain for dermatology programs to improve website transparency and aid applicants in this difficult-to-navigate process. These results identify real transparency gaps, with several potential foci for improvement. Our main study limitation is its focus on a single time-period; to ensure that this information remains up to date, ongoing efforts to periodically resurvey content changes is warranted. Our findings provide an overview of programs' successes and remaining opportunities to follow published transparency guidelines; overall, these findings may guide individual program directors aiming to improve the transparency of their dermatology residency programs and ultimately benefit our future workforce.
随着 COVID-19 大流行的爆发,皮肤科住院医师申请流程在多个方面迅速转变。由于取消了面对面活动,并且 USMLE Step 1 变为通过/不通过,因此提出了一些改革建议以增强该流程,包括提高透明度。鉴于大多数皮肤科申请人使用项目网站来了解更多有关潜在住院医师计划的信息,我们进行了一项横断面研究,以量化皮肤科住院医师计划网站的透明度,相对于已发布的指南。从 2022 年 2 月 11 日至 2022 年 2 月 25 日,我们检查了所有 ACGME 认证的皮肤科住院医师计划的可用网站,以确定有关信息传播、选择标准、面试流程、计划优先级以及计划要求和机会的透明度。共有 136 个皮肤科项目(95.1%)符合纳入标准。总体而言,计划在计划要求和机会方面最为透明(87.25%)。这包括有关医院位置、亚专业诊所以及轮班/呼叫/教学计划的信息。计划在分享选择和/或排除标准方面透明度最低(31.13%),并且在分享有关面试流程的信息量方面存在差异(39.34%),以及计划优先级(64.56%)。皮肤科计划仍有机会提高网站透明度,并为申请人在这一困难的导航过程中提供帮助。这些结果确定了真正的透明度差距,并为改进提供了几个潜在重点。我们的主要研究局限性在于它专注于一个单一时期;为了确保此信息保持最新,需要定期重新调查内容变化,以确保此信息保持最新。我们的研究结果提供了计划成功和遵循已发布透明度准则的剩余机会的概述;总体而言,这些发现可能为旨在提高皮肤科住院医师计划透明度的个别项目主管提供指导,并最终使我们未来的劳动力受益。